Clinical ALD Trials

Clinical ALD Trials

Phase III Interventional Trials in ALD:

  1. A phase 2/3 study of the efficacy and safety of hematopoietic stem cells transduced with Lenti D lentiviral vector for the treatment of childhood cerebral adrenoleukodystrophy (CCALD)

    Status: Active, currently recruiting
    Disease Categories: Cerebral ALD phenotype (cerALD)

Phase II Interventional Trials in ALD:

Coming soon

Other Interventional Trials:

Coming soon